The five-month contract is with Retractable Technologies, a Texas-based medical devicemaker.
The low dead space safety syringes are needed to extract six doses of Pfizer’s COVID-19 vaccine from their vials, which were originally labeled to contain five.
HHS is able to exercise up to seven one-month extensions of the contract, which would cost a maximum of $92.7 million.
More articles on supply chain:
Pandemic spurring hospital shortage of pipette tips, sterile water, analysis finds
Millions of COVID-19 tests purchased by US going unused
US investigating millions of counterfeit N95 masks sent to hospitals
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
